PRELIMINARY PROXY STATEMENT

Company

Tonix Pharmaceuticals Holding Corp.

Filed

May 15, 2020

Period of Report

June 26, 2020

Accession Number

0001387131-20-004903

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →